title: Monitoring may need to be prolonged in patients given warfarin and amiodarone.
authors.forename: B
authors.initials: B
authors.lastname: Tomlinson
authors.forename: R P
authors.initials: RP
authors.lastname: Young
authors.forename: T Y
authors.initials: TY
authors.lastname: Chan
authors.forename: J A
authors.initials: JA
authors.lastname: Critchley
authors.forename: J C
authors.initials: JC
authors.lastname: Chan
mesh_terms: D000638:Amiodarone / Q000009:adverse effects*; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D000925:Anticoagulants / Q000009:adverse effects*; D044466:Asian People; D002681:China / Q000208:ethnology; D004347:Drug Interactions; D006723:Hong Kong / Q000208:ethnology; D006801:Humans; D014859:Warfarin / Q000009:adverse effects*
chemical_list: D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D014859:Warfarin; D000638:Amiodarone